2nd Quarter - Report

TARPLIN, DOWNS & YOUNG, LLC for VERTEX PHARMACEUTICALS INCORPORATED

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

**see addendum page ***, no specific bill, Raising Awareness of Hepatitis C, HHS National Strategy ***, no specific bill, public health funding for Hepatitis, appropriations for the Department of Health and Human Services, screening guidelines PL 111-148 - The Patient Protection and Affordable Care Act, implementation H.R. 1217 - to Repeal the Prevention and Public Health Fund.

LobbyistCovered position, as disclosed
RAISSA H DOWNS —
MICHELLE P EASTON —
ISAAC A FORDJOUR —
LINDA E TARPLIN —
JENNIFER B YOUNG —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Agency for Healthcare Research & Quality (AHRQ); SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 1217 (112th)

Budget/Appropriations BUD

**see addendum page budget resolution, health care reform, prevention fund, debt ceiling negotiations H.R. 1473, Final Fiscal Year 2011 Continuing Resolution House Budget Resolution H.R. 1, Full-Year Continuing Appropriations Act, 2011

LobbyistCovered position, as disclosed
RAISSA H DOWNS Prin. Dep. Asst. Sec. for Leg. - HHS; Dep. Asst.
MICHELLE P EASTON Chief Health Counsel, Sen. Cmte. On Finance;
ISAAC A FORDJOUR —
LINDA E TARPLIN Congressman Billy Tauzin
JENNIFER B YOUNG Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg.

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Agency for Healthcare Research & Quality (AHRQ)

Bills named: H.R. 1 (112th), H.R. 1473 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.